|
|
| Phases of Development | Discovery | Preclinical | Phase I | Phase II | Phase III | Registration | Marketed |
|---|
| Autoimmune | 0 | 1 | 0 | 1 | 0 | 0 | 0 | | Cancer | 1 | 5 | 2 | 1 | 0 | 0 | 0 | | Diagnostic | 0 | 0 | 0 | 1 | 0 | 0 | 0 | | Genitourinary | 0 | 0 | 0 | 0 | 1 | 0 | 0 | | Infectious | 2 | 0 | 0 | 1 | 0 | 0 | 1 | | Inflammation | 0 | 3 | 0 | 0 | 0 | 0 | 1 | | Musculoskeletal | 0 | 0 | 0 | 0 | 0 | 0 | 1 | | Neurology | 2 | 0 | 2 | 0 | 0 | 0 | 1 | | Ophthalmic | 0 | 0 | 0 | 0 | 0 | 1 | 1 | | Other | 1 | 0 | 0 | 0 | 1 | 0 | 0 | | Pulmonary | 0 | 2 | 0 | 0 | 0 | 0 | 0 |
|
|
Products Targeting Undisclosed